title: [Malignant maxillofacial extra-nodal lymphoma].
abstract: 64 patients with extra-nodal maxillo-facial NHL were seen between 1969 and 1989. These rare tumours (1 to 4% of stomatological tumours) tended to occur more often in men (60% of cases) between the ages of 40 and 70. Bony involvement was common (maxillary and mandibular involvement), though more rarely the salivary glands or mucosa were involved, presenting as a swelling with lysis of underlying bone. Highly malignant varieties (85% of cases) were most commonly encountered. The treatment remains medical, involving chemotherapy (C.H.O.P. or high dose methotrexate) and gives an actuarial survival rate of 50% at 3 years.
authors: Service de stomatologie et chirurgie maxillo-faciale, C.H.U. Pitié-Salpêtrière, Paris.
authors: H
authors: H
authors: Szpirglas
authors: P
authors: P
authors: Goudot
authors: A
authors: A
authors: Thomas
authors: F
authors: F
authors: Guilbert
authors: J M
authors: JM
authors: Vaillant
authors: E
authors: E
authors: Touboul
authors: D
authors: D
authors: Nizri
mesh_terms: D000328:Adult; D000368:Aged; D005153:Facial Neoplasms / Q000473:pathology*; D005260:Female; D006801:Humans; D007573:Jaw Neoplasms / Q000473:pathology*; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology*; D008297:Male; D008875:Middle Aged
vernacular_title: Lymphomes malins maxillo-faciaux extra-ganglionnaires.